Michelle Pearlman1, Jon Obert2, Lisa Casey3. 1. Department of Medicine, Division of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, 5323 Harry Hines, K5.136, Dallas, TX, 75390, USA. pearlmanmi@gmail.com. 2. Division of Gastroenterology and Hepatology, University of Louisville, Louisville, KY, USA. 3. Department of Medicine, Division of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, 5323 Harry Hines, K5.136, Dallas, TX, 75390, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this paper is to review the epidemiology of obesity and the evolution of artificial sweeteners; to examine the latest research on the effects of artificial sweeteners on the host microbiome, the gut-brain axis, glucose homeostasis, and energy consumption; and to discuss how all of these changes ultimately contribute to obesity. RECENT FINDINGS: Although artificial sweeteners were developed as a sugar substitute to help reduce insulin resistance and obesity, data in both animal models and humans suggest that the effects of artificial sweeteners may contribute to metabolic syndrome and the obesity epidemic. Artificial sweeteners appear to change the host microbiome, lead to decreased satiety, and alter glucose homeostasis, and are associated with increased caloric consumption and weight gain. Artificial sweeteners are marketed as a healthy alternative to sugar and as a tool for weight loss. Data however suggests that the intended effects do not correlate with what is seen in clinical practice. Future research should focus on the newer plant-based sweeteners, incorporate extended study durations to determine the long-term effects of artificial sweetener consumption, and focus on changes in the microbiome, as that seems to be one of the main driving forces behind nutrient absorption and glucose metabolism.
PURPOSE OF REVIEW: The purpose of this paper is to review the epidemiology of obesity and the evolution of artificial sweeteners; to examine the latest research on the effects of artificial sweeteners on the host microbiome, the gut-brain axis, glucose homeostasis, and energy consumption; and to discuss how all of these changes ultimately contribute to obesity. RECENT FINDINGS: Although artificial sweeteners were developed as a sugar substitute to help reduce insulin resistance and obesity, data in both animal models and humans suggest that the effects of artificial sweeteners may contribute to metabolic syndrome and the obesity epidemic. Artificial sweeteners appear to change the host microbiome, lead to decreased satiety, and alter glucose homeostasis, and are associated with increased caloric consumption and weight gain. Artificial sweeteners are marketed as a healthy alternative to sugar and as a tool for weight loss. Data however suggests that the intended effects do not correlate with what is seen in clinical practice. Future research should focus on the newer plant-based sweeteners, incorporate extended study durations to determine the long-term effects of artificial sweetener consumption, and focus on changes in the microbiome, as that seems to be one of the main driving forces behind nutrient absorption and glucose metabolism.
Authors: Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti Journal: Proc Natl Acad Sci U S A Date: 2010-08-02 Impact factor: 11.205
Authors: Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2004-10-25 Impact factor: 11.205
Authors: Meghan B Azad; Alyssa Archibald; Mateusz M Tomczyk; Alanna Head; Kyle G Cheung; Russell J de Souza; Allan B Becker; Piushkumar J Mandhane; Stuart E Turvey; Theo J Moraes; Malcolm R Sears; Padmaja Subbarao; Vernon W Dolinsky Journal: Int J Obes (Lond) Date: 2020-05-04 Impact factor: 5.095
Authors: Emily N C Manoogian; Lisa S Chow; Pam R Taub; Blandine Laferrère; Satchidananda Panda Journal: Endocr Rev Date: 2022-03-09 Impact factor: 25.261
Authors: Sofie Stampe; Magnus Leth-Møller; Eva Greibe; Elke Hoffmann-Lücke; Michael Pedersen; Per Ovesen Journal: Nutrients Date: 2022-06-25 Impact factor: 6.706
Authors: Fernanda Rauber; Kiara Chang; Eszter P Vamos; Maria Laura da Costa Louzada; Carlos Augusto Monteiro; Christopher Millett; Renata Bertazzi Levy Journal: Eur J Nutr Date: 2020-10-18 Impact factor: 5.614
Authors: Edward L Giovannucci; Kana Wu; Emilie S Zoltick; Stephanie A Smith-Warner; Chen Yuan; Molin Wang; Charles S Fuchs; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Shuji Ogino; Meir J Stampfer Journal: Br J Cancer Date: 2021-07-15 Impact factor: 9.075